| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.3M | +55.2% |
| R&D Expense | $34.1M | +55.2% |
| SG&A Expense | $40.8M | +92.2% |
| Operating Income | -$70.6M | -74.6% |
| Net Income | -$58.2M | -5.2% |
| EPS (Basic) | -$2.23 | +88.3% |
| EPS (Diluted) | -$2.23 | +88.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.6M | +6379.2% |
| Short-term Investments | $40.9M | — |
| Accounts Receivable | $626K | +29.6% |
| Current Assets | $102.6M | +7806.7% |
| Total Assets | $180.8M | -21.9% |
| Current Liabilities | $18.1M | +450.0% |
| Total Liabilities | $53.5M | +418.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.9M | -0.8% |
| Capital Expenditures | $41.4M | +646.4% |
| Investing Cash Flow | -$82.0M | -1378.6% |
| Financing Cash Flow | $118.6M | +73.2% |
| Free Cash Flow | -$76.3M | -89.8% |
| Stockholders' Equity |
| $127.3M |
| +1533.9% |